VREX Stock Analysis: Buy, Sell, or Hold?
VREX - Varex Imaging Corporation Common Stock
$10.92
0.20 (1.87%)
▲
5d:
+3.51%
30d:
+5.3%
90d:
-10.93%
BUY
MODERATE Confidence
Analysis Updated: Jul 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
10d
Get Alerted When VREX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VREX shows positive signals but monitor for confirmation. Market pricing in 4.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: VREX shows positive signals but monitor for confirmation. Market pricing in 4.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.45
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.18
28.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VREX is currently trading at $10.92, which is considered extended relative to its 30-day fair value range of $10.36 to $10.82. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.3) compared to its historical average (11.8). Remarkably, the market is currently pricing in an annual earnings decline of 4.5% over the next few years. This pessimistic expectation contrasts with the company's recent 453.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, VREX is in a downtrend. The price is approaching resistance at $11.23. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: VREX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.00 (+64.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VREX is in a downtrend. The price is approaching resistance at $11.23. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: VREX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.00 (+64.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.36 -
$10.82
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 64.8% below Wall St target ($18.00)
Trading Range Analysis
30-Day Trading Range
$10.36 -
$10.82
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$10.01
Resistance Level
$11.23
Current Trend
Downtrend
Technical data as of
Jul 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.26
Wall Street Target
$18.00
(+64.8%)
Revenue Growth (YoY)
1.5%
Earnings Growth (YoY)
453.4%
Profit Margin
-9.6%
Valuation Discount vs History
-4.5% cheaper
PE vs Historical
10.3 vs 11.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.5%
(market-implied from PE analysis)
1-Year Target
$10.43
(-5%)
2-Year Target
$9.96
(-9%)
3-Year Target
$9.51
(-13%)
3-Yr Target (if PE normalizes)
(PE: 10→12)
$10.94
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.8, Growth: 36.8%)
$56.64
(+419%)
Base:
(SPY PE: 10.3, Growth: 36.8%)
$27.93
(+156%)
Bear:
(PE: 8.7, Growth: 36.8%)
$23.74
(+117%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.3 to 11.8
Stabilization Target:
$12.56
(+15.0%)
PE Expansion Potential:
+15.0%
Share & Embed Analysis
Last updated: July 26, 2026 9:41 AM ET
Data refreshes hourly during market hours. Next update: 10:41 AM
Data refreshes hourly during market hours. Next update: 10:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VREX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jay K Kunkel
SELL
4510 shares
2026-03-20
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$72 | 54 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 47 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$238 | 50 HOLD |
